WASHINGTON, D.C. — Following scientific review by the U.S. Food and Drug Administration (FDA), the agency issued a renewal of ...

CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA ...

The FDA approved zolbetuximab (Vyloy) on October 18, 2024, as a first-line treatment for locally advanced unresectable or ...

The partnership with Telix, which covers North America and the European Union (EU, excluding France and French speaking Belgium), launches in the United States (U.S.) with Illuccix, with the aim to ...

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration ... This is the first approved indication for Orlynvah and Iterum's first FDA-approved product.

The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year. The Food and Drug Administration ... When a drug sponsor proposes that the FDA ...

Oct. 24, 2024 – The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer. Marketed under the brand name Vyloy, the drug is to ...

According to the release, the United States Food and Drug Administration ... However there is currently no FDA-approved ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx ...

A class II risk level is given to products that "may cause temporary or medically reversible adverse health consequences." ...